PSMC3IP and breast carcinoma: Although further studies are required to gain deeper insight into the molecular mechanisms underlying the anti-apoptotic role of PSMC3IP and EPSTI1 in breast cancer, our findings highlight them beforehand as very interesting therapeutic targets, preeminently for their ability to apoptosis sensitization.